Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension. [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating the efficacy and safety of combining TAK-536CCB with hydrochlorothiazide in patients with Grade I or II essential hypertension has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• TAK-536CCB (TAK-536CCB)

Snippet

Sponsor: Takeda | Conditions: Grade I or II Essential Hypertension | Phase 2, Phase 3 | Status: COMPLETED